跳至主要内容
临床试验/ITMCTR2000003367
ITMCTR2000003367尚未招募1 期

To investigate the immunomodulation effect of invigorating spleen and invigorating Qi on myasthenia gravis based on N-of-1 randomized controlled trial

The First Affiliated Hospital of Guangzhou University of TCM0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Patients aged 18-65 years;
  • 2. The patients with myasthenia gravis and stable condition were confirmed to have hormone dosage less than 15 mg / d;
  • 3. Patients with deficiency of spleen and stomach qi were diagnosed by traditional Chinese medicine;
  • 4. Patients who can have normal speech communication;
  • 5. Informed consent, volunteer patients.

排除标准

  • 1. Pregnant or preparing pregnant women, lactating women;
  • 2. Patients with a history of drug abuse and mental illness;
  • 3. Patients with serious primary diseases such as liver, kidney, hematopoietic system, cardiopulmonary system, endocrine system and malignant tumor.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of TCM

相似试验